treatment approval
FDA Approves Roche’s Biogen-Partnered Gazyva for Lupus Nephritis
Gazyva; obinutuzumab; Roche; Biogen; FDA; lupus nephritis; treatment approval
Actionable Insights Powered by AI
Gazyva; obinutuzumab; Roche; Biogen; FDA; lupus nephritis; treatment approval